Mumbai: Mankind Pharma announced its financial results for the second quarter and first half ended 30 September 2026, on 26 October 2026. The company's domestic business, excluding consumer healthcare, saw a 15.9 per cent year-on-year increase.
Quarterly Financials
The company’s revenue from operations for Q2 FY27 stood at ₹4,338 crore, an increase of 17.3 per cent year-on-year. Domestic revenue was ₹3,657 crore, up 14.8 per cent, while exports grew 32.7 per cent to ₹681 crore.
Profitability and Margins
EBITDA for Q2 FY27 increased 27.2 per cent to ₹1,175 crore, with the EBITDA margin improving by 210 basis points (bps) to 27.1 per cent. PAT margin also rose by 240 bps to 16.5 per cent, resulting in a PAT of ₹716 crore.
Half-Year Performance
For the first half of FY27 (H1 FY27), Mankind Pharma reported revenue from operations of ₹8,368 crore, up 15.1 per cent year-on-year. Domestic revenue for H1 FY27 was ₹7,082 crore, an increase of 12.7 per cent, and exports grew 31.0 per cent to ₹1,286 crore.
H1 Profit and Margins
EBITDA for H1 FY27 stood at ₹2,235 crore, a 26.0 per cent rise, with EBITDA margin at 26.7 per cent, an improvement of 230 bps. PAT for H1 FY27 was ₹1,290 crore, up 33.7 per cent year-on-year, with PAT margin at 15.4 per cent, an increase of 210 bps.
Business Performance
Rajeev Juneja, Vice Chairman and Managing Director, noted that the recent acquisition of Armed Cell Therapeutics marks the company’s entry into next-generation CAR-T therapies. International business grew by 33 per cent during the quarter, while consumer healthcare experienced muted growth.
Domestic Business Growth
Domestic business (excluding consumer healthcare) showed a 15.9 per cent year-on-year increase, driven by growth in both Mankind and BSV specialty segments. Secondary sales growth outperformed IPM by 1.1x in Q2 FY27, supported by strong performance in cardiac and anti-diabetes segments.
Disclaimer: This story is based on company exchange filings and is for informational purposes only. Investors should evaluate risks before making decisions.
